CCM
Concord Medical Services Holdings Limited
There isn't enough reported data to score CCM yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CCM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Weak |
CCM's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CCM PE Valuation
CCM has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CCM Forward outlook
There aren't enough analyst estimates for CCM to show an outlook.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.11 | +$0.24 |
| Q4 2024 | -$0.35 | +$3.06 |
| Q4 2023 | -$3.41 | +$2.20 |
| Q4 2020 | -$7.67 | -$1.31 |
| Q4 2019 | -$6.36 | -$2.22 |
| Q4 2018 | -$4.14 | -$0.85 |
| Q4 2017 | -$3.29 | -$0.29 |
| Q4 2016 | -$3.00 | -$2.13 |
CCM has the edge over HIMS in the latest year-over-year earnings comparison.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
CCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $69.1M | +20% |
| Q4 2024 | $57.6M | -29% |
| Q4 2023 | $80.6M | +14% |
| Q4 2022 | $70.8M | -2.8% |
| Q4 2021 | $72.9M | +118% |
| Q4 2020 | $33.5M | +12% |
| Q4 2019 | $29.8M | +3.9% |
| Q4 2018 | $28.6M | -42% |
CCM's revenue is growing: $69M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -57% | +38 points |
| Q4 2024 | -139% | +3.1 points |
| Q4 2023 | -86% | +134 points |
| Q4 2022 | -111% | +46 points |
| Q4 2021 | -94% | -30 points |
| Q4 2020 | -142% | -105 points |
| Q4 2019 | -220% | -220 points |
| Q4 2018 | -157% | -187 points |
CCM's operating margin was โ57% last quarter, up 38 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over CCM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was โ7.4% last quarter, down 9.4 points from the same quarter a year ago.
CCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$38.7M | +$43.6M |
| Q4 2024 | -$82.3M | -$23.9M |
| Q4 2023 | -$58.4M | +$7.5M |
| Q4 2022 | -$66M | +$29.8M |
| Q4 2021 | -$95.8M | -$36.1M |
| Q4 2020 | -$59.7M | +$4.5M |
| Q4 2019 | -$64.2M | -$33.6M |
| Q4 2018 | -$30.6M | -$21M |
CCM has burned cash in most quarters: โ$245M over the past year, against โ$250M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS still generates free cash flow, though less than at its 2024 peak: $8M over the past year.
CCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2015 | 4.7x | High |
| Q4 2014 | 1.1x | Healthy |
| Q4 2013 | 2.2x | Moderate |
| Q4 2012 | 2.3x | Moderate |
CCM's net debt is about 4.7 years of its operating earnings (EBITDA).
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
CCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 28.6 | Neutral |
CCM's weekly RSI is 44 (neutral) and its Stochastic is 29 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CCM PE vs Healthcare Sector
CCM has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | โ |
HIMS has no meaningful PE right now: it lost money over the past year.
CCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.65 | 2.7% below |
| 20 week MA | $4.17 | 15% below |
| 50 week MA | $4.24 | 16% below |
| 100 week MA | $4.79 | 26% below |
| 200 week MA | $7.27 | 51% below |
CCM is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $29.1 | +6.6% |
| 2021 | $29.1 | $20.5 | -30% |
| 2022 | $20.5 | $16.6 | -19% |
| 2023 | $16.6 | $11.0 | -34% |
| 2024 | $11.0 | $5.02 | -54% |
| 2025 | $5.02 | $3.76 | -25% |
| 2026 YTD | $3.76 | $3.55 | -5.6% |
CCM has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to โ56% in 2021. It's down 42% so far in 2026.